BIM
GSK icon

Baldwin Investment Management’s GSK GSK Stock Holding History

Baldwin Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,326
Closed -$215K – 250
2021
Q2 		$215K Sell
4,326
-474
-10% -$22.8K 0.04% 238
2021
Q1 		$214K Sell
4,800
-2,720
-36% -$123K 0.04% 235
2020
Q4 		$346K Sell
7,520
-6,440
-46% -$296K 0.07% 174
2020
Q3 		$657K Buy
+13,960
New +$699K 0.15% 105
2020
Q1 		– Sell
-3,440
Closed -$202K – 148
2019
Q4 		$202K Buy
+3,440
New +$191K 0.05% 167

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baldwin Investment Management's GSK Position: Q3 2021 in Review

Baldwin Investment Management sold out of GSK (GSK) in Q3 2021, closing a stake of 4,326 shares — an estimated $215K sold.

Baldwin Investment Management first reported a position in GSK in Q4 2019 and held it in 5 quarters. The position peaked at $657K in Q3 2020. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Baldwin Investment Management reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
  • Baldwin Investment Management sold 4,326 GSK shares in Q3 2021, an estimated $215K.
  • Baldwin Investment Management first reported a position in GSK in Q4 2019 and held it in 5 quarters.
  • Baldwin Investment Management's GSK position peaked at $657K in Q3 2020.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Baldwin Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.